Novavax, Inc. (NVAX): Price and Financial Metrics

NVAX POWR Grades

• NVAX scores best on the Value dimension, with a Value rank ahead of 91.34% of US stocks.
• The strongest trend for NVAX is in Growth, which has been heading up over the past 179 days.
• NVAX's current lowest rank is in the Sentiment metric (where it is better than 0.69% of US stocks).

NVAX Stock Summary

• Novavax Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 2.81% of US listed stocks.
• Of note is the ratio of Novavax Inc's sales and general administrative expense to its total operating expenses; merely 4.02% of US stocks have a lower such ratio.
• Revenue growth over the past 12 months for Novavax Inc comes in at 141.02%, a number that bests 94.45% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Novavax Inc are ARDS, CKPT, RVMD, ZYME, and AUTL.
• NVAX's SEC filings can be seen here. And to visit Novavax Inc's official web site, go to www.novavax.com.

NVAX Valuation Summary

• In comparison to the median Healthcare stock, NVAX's price/earnings ratio is 151.23% lower, now standing at -18.7.
• NVAX's price/sales ratio has moved down 7.3 over the prior 243 months.
• NVAX's price/sales ratio has moved down 7.3 over the prior 243 months.

Below are key valuation metrics over time for NVAX.

NVAX Growth Metrics

Its year over year net income to common stockholders growth rate is now at -433.31%.
• Its 5 year net cashflow from operations growth rate is now at 34.04%.
• Its year over year revenue growth rate is now at 4991.93%.

Over the past 52 months, NVAX's revenue has gone up $1,120,127,000.

The table below shows NVAX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,146.29	322.946	-1,743.751
2021-09-30	1,203.749	536.786	-1,075.031
2021-06-30	1,181.929	672.432	-949.91
2021-03-31	919.45	643.654	-615.114
2020-12-31	475.598	-42.541	-418.259
2020-09-30	204.755	62.284	-272.525

NVAX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• NVAX has a Quality Grade of C, ranking ahead of 58.82% of graded US stocks.
• NVAX's asset turnover comes in at 0.6 -- ranking 60th of 680 Pharmaceutical Products stocks.
• GTHX, SRRA, and OPK are the stocks whose asset turnover ratios are most correlated with NVAX.

The table below shows NVAX's key quality metrics over time.